101 related articles for article (PubMed ID: 35702620)
21. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
22. Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance.
Ren SY; Wang WB; Gao RD; Zhou AM
World J Clin Cases; 2022 Jan; 10(1):1-11. PubMed ID: 35071500
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar.
Butt AA; Dargham SR; Tang P; Chemaitelly H; Hasan MR; Coyle PV; Kaleeckal AH; Latif AN; Loka S; Shaik RM; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
J Glob Health; 2022 Jul; 12():05032. PubMed ID: 35788085
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape.
Sanyaolu A; Marinkovic A; Prakash S; Haider N; Williams M; Okorie C; Badaru O; Smith S
World J Virol; 2022 May; 11(3):137-143. PubMed ID: 35665238
[TBL] [Abstract][Full Text] [Related]
26. Update on omicron variant: What we know so far.
Choudhary G; Prajapat M; Kumaravel J; Prabha PK; Sarma P; Handa V; Kaur H; Patel AP; Medhi B
Indian J Pharmacol; 2022; 54(1):41-45. PubMed ID: 35343206
[TBL] [Abstract][Full Text] [Related]
27. Clinical Profile and Outcome of Hospitalized Confirmed Cases of Omicron Variant of SARS-CoV-2 Among Children in Pune, India.
Kinikar AA; Vartak S; Dawre R; Valvi C; Kamath P; Sonkawade N; Pawar S; Bhagat V; A K; Nawale K; Deshmukh I; Das R; Kulkarni RK; Potdar V; Karyakarte R
Cureus; 2022 Apr; 14(4):e24629. PubMed ID: 35664398
[TBL] [Abstract][Full Text] [Related]
28. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N
Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176
[TBL] [Abstract][Full Text] [Related]
29. Case Report: The Experience of Managing a Moderate ARDS Caused by SARS-CoV-2 Omicron BA.2 Variant in Chongqing, China: Can We Do Better?
Peng J; Li Q; Dong J; Yuan G; Wang D
Front Med (Lausanne); 2022; 9():921135. PubMed ID: 35755038
[TBL] [Abstract][Full Text] [Related]
30. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
[TBL] [Abstract][Full Text] [Related]
31. Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations.
Almeida LT; Gonçalves AB; Franco-Luiz APM; Silva TBS; Alves PA; Monte-Neto RLD
Mem Inst Oswaldo Cruz; 2022; 117():e220050. PubMed ID: 35766650
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
[No Abstract] [Full Text] [Related]
33. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
CDC COVID-19 Response Team
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
[TBL] [Abstract][Full Text] [Related]
35. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.
Lu J; Yin Q; Pei R; Zhang Q; Qu Y; Pan Y; Sun L; Gao D; Liang C; Yang J; Wu W; Li J; Cui Z; Wang Z; Li X; Li D; Wang S; Duan K; Guan W; Liang M; Yang X
Virol Sin; 2022 Apr; 37(2):238-247. PubMed ID: 35527227
[TBL] [Abstract][Full Text] [Related]
36. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
[TBL] [Abstract][Full Text] [Related]
37. An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.
Rathinasamy M; Kandhasamy S
J Med Virol; 2022 Jun; 94(6):2414-2421. PubMed ID: 35112734
[TBL] [Abstract][Full Text] [Related]
38. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Omicron Variant is Expected to Retain Most of the Spike Protein Specific Dominant T-Cell Epitopes Presented by COVID-19 Vaccines - Worldwide, 2021.
Jiang J; Du Y; Peng T
China CDC Wkly; 2022 May; 4(18):381-384. PubMed ID: 35686202
[TBL] [Abstract][Full Text] [Related]
40. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
